Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-021025
Filing Date
2025-08-05
Accepted
2025-08-05 16:07:52
Documents
1
Period of Report
2025-08-01

Document Format Files

Seq Description Document Type Size
1 form4-08052025_080848.html 4  
1 form4-08052025_080848.xml 4 7729
  Complete submission text file 0001415889-25-021025.txt   11114
Mailing Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043
Business Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043 650-253-0000
Alphabet Inc. (Reporting) CIK: 0001652044 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41536 | Film No.: 251184995
SIC: 7370 Services-Computer Programming, Data Processing, Etc.
(CF Office: 06 Technology)

Mailing Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043
Business Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043 650-253-0000
GV 2021, L.P. (Reporting) CIK: 0001861202 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41536 | Film No.: 251184996

Mailing Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043
Business Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043 650-253-0000
GV 2021 GP, L.L.C. (Reporting) CIK: 0001861206 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41536 | Film No.: 251184998

Mailing Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043
Business Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043 650-253-0000
GV 2021 GP, L.P. (Reporting) CIK: 0001861216 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41536 | Film No.: 251184997

Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Issuer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)